Emergen Research Logo

Rising incidence of cardiovascular diseases & increasing geriatric population are significant factor driving interventional cardiology devices market growth.

VANCOUVER, BC, CANADA, March 16, 2022 /EINPresswire.com/ -- The Global Interventional Cardiology Devices Market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady growth of the interventional cardiology devices market can be attributed to rising incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the US, and is responsible for around 655,000 deaths every year.

Coronary heart disease is the leading heart disease type that, in 2017, accounted for the deaths of 365,914 individuals in the US. Interventional cardiology devices deliver several benefits, including reduced chances of scar occurrence, reduced surgery complexity and time, and decreased pain.

Additionally, rising incidence of cardiovascular diseases result in an increase in healthcare expenditure, which in turn, is driving revenue growth of the interventional cardiology devices market. According to the Centers for Disease Control and Prevention, heart attacks account for over USD 320.00 Billion in yearly healthcare expenditure and lost productivity, and this figure is expected to reach USD 818.00 Billion in 2030.

Key players in the market include :
Abbott Laboratories, Terumo Corporation, iVascular, Boston Scientific Corporation, Edwards Lifesciences Corporation, B.Braun Melsungen, Medtronic PLC, Koninklijke Philips NV, Biosensors International Group Ltd., and Endocor GmbH.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/541

Some Key Highlights in the Report
In June 2019, Terumo Corporation signed a partnership agreement with Orchestra BioMed, Inc. This partnership provides Terumo Corporation with exclusive rights for the development and marketing of Virtue Sirolimus-Eluting Balloon (SEB).

Angioplasty stents find application to restore blood flow occurring due to blockage and to reduce heart attack risk. Stents are considered beneficial in reducing damage caused to heart muscles in the event of a heart attack. Also, stents may instantly relieve or reduce symptoms comprising chest pain, fatigue, and shortness of breath.

Among the end-use segments, the hospitals segment accounted for largest revenue share in 2020, which can be attributed to robust presence of experienced healthcare professionals for installation of interventional cardiology devices and more advanced and developed healthcare infrastructure, along with high purchasing power for advanced and dedicated interventional cardiology devices in countries in the region. Additionally, hospitals account for adverse event minimization in patients during critical procedures, including stent installation and cardiac catheterization.

Among the regional markets, the interventional cardiology devices market in North America accounted for largest revenue share in 2020. This can be attributed to growing awareness about cardiovascular diseases, high deployment of advanced interventional cardiological treatments, and well-developed healthcare infrastructure in countries in the region. Additionally, robust presence of leading interventional cardiology device providers in the region is another key factor causative of steady market growth.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/570

Emergen Research has segmented the global interventional cardiology devices market on the basis of product type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Angioplasty Stents
Angioplasty Balloons
Catheters
Structural Heart Devices
Plaque Modification Devices
Guidewires
Hemodynamic Flow Alteration Devices
Others

End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Ambulatory Surgical Centers
Others

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/interventional-cardiology-devices-market

Regional Outlook (Revenue, USD Million; 2021–2028)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of MEA

Overview of the Interventional Cardiology Devices Market Report:
Introduction, Product Scope, Market Overview, and Opportunities
Analysis of the Manufacturers with sales, revenue, and price analysis
Comprehensive analysis of the competitive landscape
Extensive profiling of the key competitors along with their business strategies and market size
Regional analysis of the market along with sales, revenue, market share, and global position
Country-wise analysis of the market along with types, applications, and manufacturing
Strategic recommendations to established players as well as new entrants
In-depth analysis of the risks, restraints, and limitations in the Interventional Cardiology Devices industry

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/570

Thank you for reading our report. Please connect with us to know more about the report or the customization of the report. Our team will ensure the report is best suited to meet your requirements.

Eric Lee
Emergen Research
+16047579756 ext.
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.